3M wins BioWhittaker lawsuit:
This article was originally published in Clinica
3M has won the lawsuit brought by BioWhittaker alleging breach of contract of sale and negligent representations regarding European counterparts of patents (see Clinica No 635, p 17). As a result of the decision, BioWhittaker will take a one-time charge against earnings of approximately $3.4 million reflecting expenses it incurred in connection with the suit.
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.